Good Manufacturing Practice-Compliant Expansion of Marrow-Derived Stem and Progenitor Cells for Cell Therapy
Ex vivo expansion is being used to increase the number of stem and progenitor cells for autologous cell therapy. Initiation of pivotal clinical trials testing the efficacy of these cells for tissue repair has been hampered by the challenge of assuring safe and high-quality cell production. A strateg...
Main Authors: | Martin H. Gastens, Kristin Goltry, Wolfgang Prohaska, Diethelm Tschöpe, Bernd Stratmann, Dirk Lammers, Stanley Kirana, Christian Götting, Knut Kleesiek |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2007-08-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/000000007783465172 |
Similar Items
-
Stem cell therapy in diabetic foot patients: where are we now?
by: Stanley Kirana, et al.
Published: (2011-05-01) -
Proteoglycan Biosynthesis during Chondrogenic Differentiation of Mesenchymal Stem Cells
by: Christian Götting, et al.
Published: (2007-01-01) -
Characterisation of bone marrow progenitor cells in disease
by: Gowers, Kate Hayley Christine
Published: (2013) -
Generation of Oligodendrocyte Progenitor Cells From Mouse Bone Marrow Cells
by: Yuan Zhang, et al.
Published: (2019-06-01) -
Benfotiamine Counteracts Smoking-Induced Vascular Dysfunction in Healthy Smokers
by: Alin Stirban, et al.
Published: (2012-01-01)